Well-differentiated systemic mastocytosis showed excellent clinical response to imatinib in the absence of known molecular genetic abnormalities: A case report

INTRODUCTION: Well-differentiated systemic mastocytosis (WDSM) is a rare, recently recognized provisional subvariant of systemic mastocytosis (SM). We report a case of WDSM that showed excellent clinical and cutaneous response to imatinib in the absence of known molecular genetic abnormalities. CLIN...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Lanshan, Wang, Sa A., Konoplev, Sergej, Bueso-Ramos, Carlos E., Thakral, Beenu, Miranda, Roberto N., Jabbour, Elias, Medeiros, L. Jeffrey, Kanagal-Shamanna, Rashmi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072932/
https://www.ncbi.nlm.nih.gov/pubmed/27741105
http://dx.doi.org/10.1097/MD.0000000000004934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072932/
https://www.ncbi.nlm.nih.gov/pubmed/27741105
http://dx.doi.org/10.1097/MD.0000000000004934

Ejemplares similares